Anti-Tumour Efficacy of Capecitabine in a Genetically Engineered Mouse Model of Pancreatic Cancer

Capecitabine (CAP) is a 5-FU pro-drug approved for the treatment of several cancers and it is used in combination with gemcitabine (GEM) in the treatment of patients with pancreatic adenocarcinoma (PDAC). However, limited pre-clinical data of the effects of CAP in PDAC are available to support the u...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Courtin, Aurélie, Richards, Frances M., Bapiro, Tashinga E., Bramhall, Jo L., Neesse, Albrecht, Cook, Natalie, Krippendorff, Ben-Fillippo, Tuveson, David A., Jodrell, Duncan I.
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2013
Teme:
Research Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3696095/
https://ncbi.nlm.nih.gov/pubmed/23840665
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0067330
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki